Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia AML”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01321346
What this trial is testing

Panobinostat In Children With Refractory Hematologic Malignancies

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more
Therapeutic Advances in Childhood Leukemia Consortium 30
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Large-scale testing (Phase 3)UnknownNCT01015742
What this trial is testing

Unrelated Double Umbilical Cord Blood Units Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myeloid, Chronic
Tehran University of Medical Sciences 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07026942
What this trial is testing

Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML

Who this might be right for
Relapsed/Refractory AML
Nationwide Children's Hospital 42
Early research (Phase 1)Looking for participantsNCT06498973
What this trial is testing

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 43
Post-approval studies (Phase 4)UnknownNCT02933333
What this trial is testing

G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaLymphoma+3 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 405
Testing effectiveness (Phase 2)UnknownNCT03181815
What this trial is testing

Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRelapse Leukemia
Sun Yat-sen University 48
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Early research (Phase 1)Study completedNCT01127009
What this trial is testing

Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Case Comprehensive Cancer Center 3
Very early researchUnknownNCT05519384
What this trial is testing

Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, ChildhoodRelapsed LeukemiaRefractory Leukemia
Institute of Hematology & Blood Diseases Hospital, China 12
Not applicableNot Yet RecruitingNCT07743047
What this trial is testing

Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor Functionality

Who this might be right for
Acute Myeloid Leukemia
IRCCS San Raffaele 65
Not applicableUnknownNCT05735704
What this trial is testing

Early Detection and Screening of Hematological Malignancies - SANGUINE

Who this might be right for
Hematologic Malignancy
JaxBio Ltd 3,000
Early research (Phase 1)Looking for participantsNCT03826992
What this trial is testing

Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Children's Hospital Medical Center, Cincinnati 21
Not applicableNot Yet RecruitingNCT06841952
What this trial is testing

Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid Leukemia

Who this might be right for
AML, Adult
The First Affiliated Hospital of Soochow University 158
Testing effectiveness (Phase 2)Active Not RecruitingNCT05197426
What this trial is testing

Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Bristol-Myers Squibb 19
Testing effectiveness (Phase 2)Study completedNCT01408563
What this trial is testing

Reduced Intensity Double Umbilical Cord Blood Transplantation

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMultiple Myeloma+2 more
Massachusetts General Hospital 33
Testing effectiveness (Phase 2)UnknownNCT06141304
What this trial is testing

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Who this might be right for
Relapsed Adult ALLRelapsed Adult AML
The First Hospital of Jilin University 28
Testing effectiveness (Phase 2)Looking for participantsNCT03586609
What this trial is testing

Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 145
Testing effectiveness (Phase 2)Study completedNCT01795378
What this trial is testing

Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Asan Medical Center 56
Early research (Phase 1)Study completedNCT00004009
What this trial is testing

R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Maryland, Baltimore
Next Page